To identify immune cells that are important for reducing BPTF KD tumor growth, we repeated our tumor studies in mice depleted of NK cells, CD8+ T cells, or CD4+ T cells by monoclonal antibody (mAb) treatments. Here, CD4 is linked to neoplasm.